New Fast Acting Fiasp Insulin Approved for USA

Fiasp, the latest release of insulin from Novo Nordisk, has been approved by the FDA for sale in the United States, making it the first-ever fast-acting insulin to be available in both FlexTouch and pen delivery options. Fiasp flextouch is designed to provide an ultra-fast onset of action and provide the same long duration of …

Continue reading "New Fast Acting Fiasp Insulin Approved for USA"